Inhalation of dimethyl fumarate-encapsulated solid lipid nanoparticles attenuate clinical signs of experimental autoimmune encephalomyelitis and pulmonary inflammatory dysfunction in mice was written by Pinto, Barbara Fernandes;Ribeiro, Lorena Natasha Brito;da Silva, Gisela Bevilacqua Rolfsen Ferreira;Freitas, Camila Simoes;Kraemer, Lucas;Oliveira, Fabricio Marcus Silva;Climaco, Marianna Carvalho;Mourao, Flavio Afonso Goncalves;dos Santos, Gabryella Soares Pinheiro;Bela, Samantha Ribeiro;da Silva Gurgel, Isabella Luisa;de Lima Leite, Fabio;Gomes de Oliveira, Anselmo;da Pascoa Vilela, Maura Regina Silva;Oliveira-Lima, Onesia Cristina;Soriani, Frederico Marianetti;Fujiwara, Ricardo Toshio;Birbrair, Alexander;Russo, Remo Castro;Carvalho-Tavares, Juliana. And the article was included in Clinical Science in 2022.COA of Formula: C21H44O5 The following contents are mentioned in the article:
The FDA-approved Di-Me Fumarate (DMF) as an oral drug for Multiple Sclerosis (MS) treatment based on its immunomodulatory activities. However, it also caused severe adverse effects mainly related to the gastrointestinal system. Investigated the potential effects of solid lipid nanoparticles (SLNs) containing DMF, administered by inhalation on the clin. signs, central nervous system (CNS) inflammatory response, and lung function changes in mice with exptl. autoimmune encephalomyelitis (EAE). EAE was induced using MOG35-55 peptide in female C57BL/6J mice and the mice were treated via inhalation with DMF-encapsulated SLN (CTRL/SLN/DMF and EAE/SLN/DMF), empty SLN (CTRL/SLN and EAE/SLN), or saline solution (CTRL/saline and EAE/saline), every 72 h during 21 days. After 21 days post-induction, EAE mice treated with DMF-loaded SLN, when compared with EAE/saline and EAE/SLN, showed decreased clin. score and weight loss, reduction in brain and spinal cord injury and inflammation, also related to the increased influx of Foxp3+ cells into the spinal cord and lung tissues. Moreover, our data revealed that EAE mice showed signs of respiratory disease, marked by increased vascular permeability, leukocyte influx, production of TNF-a and IL-17, perivascular and peribronchial inflammation, with pulmonary mech. dysfunction associated with loss of respiratory volumes and elasticity, which DMF-encapsulated reverted in SLN nebulization. Our study suggests that inhalation of DMF-encapsulated SLN is an effective therapeutic protocol that reduces not only the CNS inflammatory process and disability progression, characteristic of EAE disease, but also protects mice from lung inflammation and pulmonary dysfunction. This study involved multiple reactions and reactants, such as Glyceryl monostearate (cas: 31566-31-1COA of Formula: C21H44O5).
Glyceryl monostearate (cas: 31566-31-1) belongs to esters. Esters are also usually derived from carboxylic acids. It may also be obtained by reaction of acid anhydride or acid halides with alcohols or by the reaction of salts of carboxylic acids with alkyl halides. Liquid esters of low volatility serve as softening agents for resins and plastics. Esters also include many industrially important polymers. Polymethyl methacrylate is a glass substitute sold under the names Lucite and Plexiglas; polyethylene terephthalate is used as a film (Mylar) and as textile fibres sold as Terylene, Fortrel, and Dacron.COA of Formula: C21H44O5
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics